Xiang Xie

Dr. Xiang Xie

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2024 in Renal Failure
Verified
Journal Article
Open access
HJHui Jiang
Hui Jiang
XLXiaofeng Lan
Xiaofeng Lan
LZLinmeng Zhou
Linmeng Zhou
XXXiang Xie
Xiang Xie
Long-term uncontrolled hypertension increases the risk of kidney decompensation. This study aimed to explore the connection between albumin-corrected anion gap (ACAG) and kidney function in hypertensive patients. This study utilized data from 1988 participants diagnosed with hypertension sourced from the NHANES database. Binary logistic regression analysis and subgroup analysis were utilized to investigate the relationship between ACAG and kidney function. The study employed restricted cubic spline (RCS) to assess the non-linear associations between ACAG and eGFR, as well as ACAG and ACR. Furthermore, mediation and moderation effect analyses were carried out, with blood pressure serving as the mediator and moderator, ACAG as the independent variable, and eGFR and ACR as the dependent variables. Finally, the study developed ACAG-based models for predicting kidney function decline. Higher ACAG is identified as an independent risk factor for eGFR < 60 mL/minute/1.73 m2 and ACR ≥ 30 mg/g. Results from RCS indicate a non-linear relationship between ACAG and eGFR, as well as between ACAG and ACR. The mediation effect analysis revealed that DBP mediated the relationship between ACAG and eGFR. Analysis on moderation effect demonstrated that SBP played a significant role in moderating the interaction between ACAG and ACR. Moreover, the models based on ACAG showed strong performance. The levels of ACAG are found to be independently associated with both eGFR and ACR. Additionally, ACAG shows promise as a new and dependable biomarker for predicting the decline in kidney function in hypertensive patients.

6 July 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HJHui Jiang
Hui Jiang
YHYanbin He
Yanbin He
XLXiaofeng Lan
Xiaofeng Lan
XXXiang Xie
Xiang Xie
There is a growing body of evidence suggesting that Hashimoto’s thyroiditis (HT) may contribute to an increased risk of papillary thyroid carcinoma (PTC). However, the exact relationship between HT and PTC is still not fully understood. The objective of this study was to identify potential common biomarkers that may be associated with both PTC and HT. Three microarray datasets from the GEO database and RNA-seq dataset from TCGA database were collected to identify shared differentially expressed genes (DEGs) between HT and PTC. A total of 101 genes was identified as common DEGs, primarily enriched inflammation- and immune-related pathways through GO and KEGG analysis. We performed protein–protein interaction analysis and identified six significant modules comprising a total of 29 genes. Subsequently, tree hub genes (CD53, FCER1G, TYROBP) were selected using random forest (RF) algorithms for the development of three diagnostic models. The artificial neural network (ANN) model demonstrates superior performance. Notably, CD53 exerted the greatest influence on the ANN model output. We analyzed the protein expressions of the three genes using the Human Protein Atlas database. Moreover, we observed various dysregulated immune cells that were significantly associated with the hub genes through immune infiltration analysis. Immunofluorescence staining confirmed the differential expression of CD53, FCER1G, and TYROBP, as well as the results of immune infiltration analysis. Lastly, we hypothesise that benzylpenicilloyl polylysine and aspirinmay be effective in the treatment of HT and PTC and may prevent HT carcinogenesis. This study indicates that CD53, FCER1G, and TYROBP play a role in the development of HT and PTC, and may contribute to the progression of HT to PTC. These hub genes could potentially serve as diagnostic markers and therapeutic targets for PTC and HT.

27 April 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
RLRuiying Li
Ruiying Li
XLXiaofeng Lan
Xiaofeng Lan
XXXiang Xie
Xiang Xie
JWJun Wu
Jun Wu
RHRui Hu
Rui Hu
JGJiale Guo
Jiale Guo
To explore the diagnostic performance and feasibility of high-frame-rate contrast-enhanced ultrasound (HFR CEUS) combined with contrast vector imaging (CVI) in detecting benign and malignant superficial lymph nodes (SLNs). In this single-center prospective study conducted between October 2023 and February 2024, 38 consecutive patients with suspected SLN lesions underwent B-mode US, HFR CEUS examination, and post-processing CVI analysis. Their diagnosis was confirmed using fine-needle aspiration cytologic or histopathologic examination. The diagnostic efficacy of HFR CEUS alone and the combination of HFR CEUS with CVI for benign and malignant LN diagnosis was compared and the significance of other CVI parameters was evaluated. The final data set included 38 participants (mean age, 56 ± 16 years) with 42 SLN lesions. Both HFR CEUS alone and HFR CEUS combined with CVI examination showed differences in the contrast patterns of benign and malignant SLNs (all P < 0.001). The contrast pattern of benign LNs was predominantly centrifugal, while that of malignant LNs was primarily centripetal and hybrid and they were more likely to exhibit perfusion defects. The comparison between CVI combined with HFR CEUS examination and pathological results for the diagnosis of benign and malignant LNs showed a high level of consistency with a kappa value of 0.81. Comparison with HFR CEUS alone resulted in a kappa value of 0.66. HFR CEUS combined with CVI examination demonstrated a good performance in distinguishing benign and malignant SLNs.

26 July 2024 in World Journal of Clinical Cases
Verified
Journal Article
Open access
HJHui Jiang
Hui Jiang
RHRui Hu
Rui Hu
YWYu-Jie Wang
Yu-Jie Wang
XXXiang Xie
Xiang Xie
BACKGROUND There is a lack of literature discussing the utilization of the stacking ensemble algorithm for predicting depression in patients with heart failure (HF). AIM To create a stacking model for predicting depression in patients with HF. METHODS This study analyzed data on 1084 HF patients from the National Health and Nutrition Examination Survey database spanning from 2005 to 2018. Through univariate analysis and the use of an artificial neural network algorithm, predictors significantly linked to depression were identified. These predictors were utilized to create a stacking model employing tree-based learners. The performances of both the individual models and the stacking model were assessed by using the test dataset. Furthermore, the SHapley additive exPlanations (SHAP) model was applied to interpret the stacking model. RESULTS The models included five predictors. Among these models, the stacking model demonstrated the highest performance, achieving an area under the curve of 0.77 (95%CI: 0.71-0.84), a sensitivity of 0.71, and a specificity of 0.68. The calibration curve supported the reliability of the models, and decision curve analysis confirmed their clinical value. The SHAP plot demonstrated that age had the most significant impact on the stacking model's output. CONCLUSION The stacking model demonstrated strong predictive performance. Clinicians can utilize this model to identify high-risk depression patients with HF, thus enabling early provision of psychological interventions.

1 June 2026 in Radiology
Verified
Journal Article
Closed access
JLJianming Li
Jianming Li
CPChuan Pang
Chuan Pang
HLHuarong Li
Huarong Li
GLGuang-Jian Liu
Guang-Jian Liu
XXXiaoyan Xie
Xiaoyan Xie
PLPing Liang
Ping Liang
In this multicenter cohort, upfront ablation plus systemic therapy significantly improved both progression-free survival and overall survival in patients with colorectal liver oligometastases compared with delayed ablation.

8 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
FLFan Li
Fan Li
NXNuo Xu
Nuo Xu
JWJun Wu
Jun Wu
RHRui Hu
Rui Hu
ZCZhi Chen
Zhi Chen
XXXiang Xie
Xiang Xie
Objective: Ultrasound Resolution Microscopy (URM) is an emerging technique that provides superior delineation of tumor microvasculature. This prospective study aimed to evaluate the diagnostic value of URM in differentiating benign from malignant breast lesions. Methods: From September 2024 to October 2025, 55 patients with 57 breast masses underwent conventional ultrasound and contrast-enhanced URM. Microvascular parameters were quantitatively analyzed and cross-referenced with histopathology. To mitigate overfitting, LASSO regression was employed to screen 14 URM indices. A combined predictive model integrating core URM features with BI-RADS categorization (dichotomized at 4A) was developed and evaluated using ROC and decision curve analysis (DCA). Results: Thirty-four malignant and 23 benign masses were confirmed. Malignant lesions exhibited comprehensively elevated microvascular abundance and architectural chaos. LASSO regression distilled these features down to two core independent predictors: Vessel Count and Max Curvature. The BI-RADS-alone model yielded 100% sensitivity but extremely low specificity (30.43%). Crucially, the Combined model significantly outperformed the single-modality approaches, achieving an excellent AUC of 0.896 (vs. 0.652 for BI-RADS alone, p < 0.001). By integrating URM parameters, the Combined model maintained adequate sensitivity (73.53%) while drastically boosting specificity to 91.30%. DCA confirmed superior net clinical benefit for the combined strategy. Conclusions: Quantitative URM imaging effectively characterizes the distinct microvascular features of breast cancers. Integrating URM functional parameters with conventional BI-RADS categorization significantly improves diagnostic specificity. Consequently, this combined approach provides a reliable non-invasive strategy to optimize risk stratification, effectively minimizing false-positive diagnoses and averting unnecessary invasive biopsies in routine clinical practice.